Qiagen, a Dutch molecular diagnostic and sample prep firm with facilities in Germantown, has been acquired by diagnostics firm Thermo Fisher Scientific, Inc. The acquisition price was €39 per share in cash.
"This strategic step with Thermo Fisher will enable us to enter a promising new era and will give our employees the opportunity to have an even greater impact," Qiagen interim CEO Thierry Bernard said yesterday from Qiagen's world headquarters in Venlo, The Netherlands. Qiagen's beautiful, forest-lined campus is on the wonderfully-named Qiagen Strasse in Germantown.
No comments:
Post a Comment